• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Abdominal or Laparoscopic Hysterectomy for a Woman with an Enlarged Uterus?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE: 

  • Laparoscopic hysterectomy is recognized as being associated with reduced complications and speedier recoveries  
  • One of the reasons for still offering abdominal hysterectomy is enlarged uterus  
  • Louie et al. (AJOG, 2018) sought to determine whether  
    • Whether uterine weight increases posthysterectomy complications
    • The relationship beteween vaginal, laparoscopic and abdominal surgical approaches and related complications

METHODS: 

  • Cohort study of prospectively collected data 
    • Patients undergoing hysterectomy for benign conditions 
  • Data from the American College of Surgeons National Surgical Quality Improvement program database 
    • Patient information | 30-day postoperative outcomes | Procedure-specific risk factors and outcomes in >100 of those participating hospitals 
  • Patients were compared with respect to 30-day postoperative complications and uterine weight, stratified by surgical approach 

RESULTS: 

  • 27,167 patients were analyzed 
  • Compared to women with uteri ≤100 g (and adjusted for medical and surgical variables) women with larger uteri had more complications  
    • 500g uteri: >30% more likely to have complications 
      • Adjusted odds ratio (aOR) 1.34 (95% CI, 1.17–1.54; P < .0001) 
    • 750g uteri: ~60% more likely to have complications 
      • aOR 1.58 (95% CI, 1.37–1.82; P < .0001) 
    • ≥1000g uteri: >80% more likely to have complications   
      • aOR 1.85 (95% CI, 1.55–2.21; P < .0001) 
  • The incidence of 30-day postsurgical complications 
    • Abdominal hysterectomy: 15%  
    • Laparoscopic hysterectomy:  8%  
  • For each stratum of uterine weight abdominal hysterectomy had significantly higher odds of any complication compared to laparoscopic hysterectomy 
    • <250g uteri: Abdominal hysterectomy had twice the odds of any complication 
      • aOR 2.05 (95% CI, 1.80–2.33) 
    • 250–500g uteri: Abdominal hysterectomy was associated with an almost 80% increase in odds of any complication 
      • aOR 1.76 (95% CI, 1.41–2.19) 
    • >500g uteri: Abdominal hysterectomy was associated with >30% increased odds of any complication  
      • aOR 1.35 (95% confidence interval, 1.07–1.71)

CONCLUSION: 

  • Uterine weight increased the risk for posthysterectomy complications as an independent variable  
  • Abdominal hysterectomy had higher odds of any complication, compared to laparoscopic hysterectomy, even for enlarged uteri greater than 500g  
  • The authors state  

Our study suggests that uterine weight alone is not an appropriate indication for abdominal hysterectomy and that it is safe to perform larger hysterectomies laparoscopically. Patients may benefit from experienced surgeons who are able to offer minimally invasive approaches even for enlarged uteri. 

Learn More – Primary Sources: 

Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Evidence-Based Gynecologic Surgery Best Practices: The AHRQ Safety Program
Mode of Gynecologic Surgery and Risk for Post-Op Venous Thromboembolism

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site